Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behrang Amini

Showing results (161-170 of 173) with videos related to

Pageof 18
Sort By:
Oncology|October 21, 2016
Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 FusionVivek Subbiah, Oliver Holmes, Kyle Gowen, et al.
Journal of Neurosurgery. Spine|April 15, 2023
Risk factors for sacral fracture following en bloc chordoma resectionAnthony L Mikula, Zach Pennington, Nikita Lakomkin, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 27, 2018
Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation TherapyAlison K Yoder, Jillian R Gunther, Sarah A Milgrom, et al.
JCI Insight|April 20, 2017
First-in-human trial of multikinase VEGF inhibitor regorafenib and anti-EGFR antibody cetuximab in advanced cancer patientsVivek Subbiah, Muhammad Rizwan Khawaja, David S Hong, et al.
Cancer|July 6, 2022
Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort studyVinod Ravi, Aparna Subramaniam, Jing Zheng, et al.
Journal of the American College of Radiology : JACR|February 29, 2016
ACR Appropriateness Criteria Follow-Up of Malignant or Aggressive Musculoskeletal TumorsCatherine C Roberts, Mark J Kransdorf, Francesca D Beaman, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 21, 2024
Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation TherapyGohar S Manzar, Stephanie O Dudzinski, Alison K Yoder, et al.
Science Translational Medicine|May 31, 2019
Reprogrammed marrow adipocytes contribute to myeloma-induced bone diseaseHuan Liu, Jin He, Su Pin Koh, et al.
Journal of Neuro-Oncology|September 26, 2024
Spinal laser interstitial thermal therapy and radiotherapy for thoracic metastatic epidural spinal cord compressionMartin C Tom, Suraj Komatineni, Chenyang Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2022
Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective StudyMichael J Nathenson, Junxiao Hu, Ravin Ratan, et al.
Pageof 18

Showing results (161-170 of 173) with videos related to

Sort By:
Pageof 18
Oncology|October 21, 2016
Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 FusionVivek Subbiah, Oliver Holmes, Kyle Gowen, et al.
Journal of Neurosurgery. Spine|April 15, 2023
Risk factors for sacral fracture following en bloc chordoma resectionAnthony L Mikula, Zach Pennington, Nikita Lakomkin, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 27, 2018
Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation TherapyAlison K Yoder, Jillian R Gunther, Sarah A Milgrom, et al.
JCI Insight|April 20, 2017
First-in-human trial of multikinase VEGF inhibitor regorafenib and anti-EGFR antibody cetuximab in advanced cancer patientsVivek Subbiah, Muhammad Rizwan Khawaja, David S Hong, et al.
Cancer|July 6, 2022
Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort studyVinod Ravi, Aparna Subramaniam, Jing Zheng, et al.
Journal of the American College of Radiology : JACR|February 29, 2016
ACR Appropriateness Criteria Follow-Up of Malignant or Aggressive Musculoskeletal TumorsCatherine C Roberts, Mark J Kransdorf, Francesca D Beaman, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 21, 2024
Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation TherapyGohar S Manzar, Stephanie O Dudzinski, Alison K Yoder, et al.
Science Translational Medicine|May 31, 2019
Reprogrammed marrow adipocytes contribute to myeloma-induced bone diseaseHuan Liu, Jin He, Su Pin Koh, et al.
Journal of Neuro-Oncology|September 26, 2024
Spinal laser interstitial thermal therapy and radiotherapy for thoracic metastatic epidural spinal cord compressionMartin C Tom, Suraj Komatineni, Chenyang Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2022
Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective StudyMichael J Nathenson, Junxiao Hu, Ravin Ratan, et al.
Pageof 18